Foley_2010_Vasc.Health.Risk.Manag_6_541

Reference

Title : Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience - Foley_2010_Vasc.Health.Risk.Manag_6_541
Author(s) : Foley JE , Jordan J
Ref : Vasc Health Risk Manag , 6 :541 , 2010
Abstract : Foley_2010_Vasc.Health.Risk.Manag_6_541
ESTHER : Foley_2010_Vasc.Health.Risk.Manag_6_541
PubMedSearch : Foley_2010_Vasc.Health.Risk.Manag_6_541
PubMedID: 20730070

Related information

Citations formats

Foley JE, Jordan J (2010)
Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience
Vasc Health Risk Manag 6 :541

Foley JE, Jordan J (2010)
Vasc Health Risk Manag 6 :541